Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores.

Atzeni F, Bongiovanni S, Marchesoni A, Filippini M, Caporali R, Gorla R, Cavagna L, Favalli EG, Saccardo F, Sarzi-Puttini P.

Joint Bone Spine. 2014 Jan;81(1):37-40. doi: 10.1016/j.jbspin.2013.04.005. Epub 2013 Jun 2.

PMID:
23731638
[PubMed - indexed for MEDLINE]
2.

Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.

PMID:
16705046
[PubMed - indexed for MEDLINE]
Free Article
3.

Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register.

Kristensen LE, Kapetanovic MC, Gülfe A, Söderlin M, Saxne T, Geborek P.

Rheumatology (Oxford). 2008 Apr;47(4):495-9. doi: 10.1093/rheumatology/ken002. Epub 2008 Mar 3.

PMID:
18316338
[PubMed - indexed for MEDLINE]
Free Article
4.

Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity.

Hyrich KL, Deighton C, Watson KD; BSRBR Control Centre Consortium, Symmons DP, Lunt M; British Society for Rheumatology Biologics Register.

Rheumatology (Oxford). 2009 Oct;48(10):1323-7. doi: 10.1093/rheumatology/kep242. Epub 2009 Aug 25.

PMID:
19706737
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs.

Narvaez J, Díaz-Torné C, Ruiz JM, Hernandez MV, Torrente-Segarra V, Ros S, Rodriguez de la Serna A, Díaz-López C, Sanmartí R, Nolla JM.

Clin Exp Rheumatol. 2011 Nov-Dec;29(6):991-7. Epub 2011 Dec 22.

PMID:
22133052
[PubMed - indexed for MEDLINE]
6.

A predictive model for remission and low disease activity in patients with established rheumatoid arthritis receiving TNF blockers.

Pomirleanu C, Ancuta C, Miu S, Chirieac R.

Clin Rheumatol. 2013 May;32(5):665-70. doi: 10.1007/s10067-012-2146-6. Epub 2013 Jan 6.

PMID:
23292520
[PubMed - indexed for MEDLINE]
7.

Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register.

Karlsson JA, Kristensen LE, Kapetanovic MC, Gülfe A, Saxne T, Geborek P.

Rheumatology (Oxford). 2008 Apr;47(4):507-13. doi: 10.1093/rheumatology/ken034. Epub 2008 Feb 27.

PMID:
18304941
[PubMed - indexed for MEDLINE]
Free Article
8.

Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis -- results from the DANBIO registry.

Jawaheer D, Olsen J, Hetland ML.

J Rheumatol. 2012 Jan;39(1):46-53. doi: 10.3899/jrheum.110548. Epub 2011 Nov 15.

PMID:
22089458
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Predicting response to anti-TNF treatment in rheumatoid arthritis patients.

Atzeni F, Antivalle M, Pallavicini FB, Caporali R, Bazzani C, Gorla R, Favalli EG, Marchesoni A, Sarzi-Puttini P.

Autoimmun Rev. 2009 Mar;8(5):431-7. doi: 10.1016/j.autrev.2009.01.005. Epub 2009 Jan 27.

PMID:
19211043
[PubMed - indexed for MEDLINE]
10.

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.

Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, Gabay C, van Riel PL, Nordström DC, Gomez-Reino J, Pavelka K, Tomsic M, Kvien TK, van Vollenhoven RF.

Ann Rheum Dis. 2011 Sep;70(9):1575-80. doi: 10.1136/ard.2010.148759. Epub 2011 May 12.

PMID:
21571731
[PubMed - indexed for MEDLINE]
11.

Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study.

Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L, Dijkmans BA, Tak PP, Wolbink GJ.

Ann Rheum Dis. 2010 May;69(5):817-21. doi: 10.1136/ard.2009.112847. Epub 2009 Jul 5.

PMID:
19581278
[PubMed - indexed for MEDLINE]
12.

Anti-Ro/SSA antibodies are an independent factor associated with an insufficient response to tumor necrosis factor inhibitors in patients with rheumatoid arthritis.

Matsudaira R, Tamura N, Sekiya F, Ogasawara M, Yamanaka K, Takasaki Y.

J Rheumatol. 2011 Nov;38(11):2346-54. doi: 10.3899/jrheum.101295. Epub 2011 Oct 1.

PMID:
21965648
[PubMed - indexed for MEDLINE]
13.

Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry.

Couderc M, Gottenberg JE, Mariette X, Pereira B, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Soubrier M; Club Rhumatismes et Inflammations.

Rheumatology (Oxford). 2014 Oct;53(10):1788-93. doi: 10.1093/rheumatology/keu176. Epub 2014 May 11.

PMID:
24821852
[PubMed - indexed for MEDLINE]
14.

Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritis.

Fernández-Nebro A, Irigoyen MV, Ureña I, Belmonte-López MA, Coret V, Jiménez-Núñez FG, Díaz-Cordovés G, López-Lasanta MA, Ponce A, Rodríguez-Pérez M, Calero E, González-Santos P.

J Rheumatol. 2007 Dec;34(12):2334-42. Epub 2007 Nov 1.

PMID:
17985409
[PubMed - indexed for MEDLINE]
15.

Discrepancies between the EULAR response criteria and the NICE guidelines for continuation of anti-TNF therapy in RA: a cause for concern?

Jerram S, Butt S, Gadsby K, Deighton C.

Rheumatology (Oxford). 2008 Feb;47(2):180-2. Epub 2007 Dec 26.

PMID:
18160419
[PubMed - indexed for MEDLINE]
Free Article
16.

Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.

Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, Massara A, Nacci F, Secchi ME, Manganelli S, Salaffi F, Bambara ML, Bombardieri S, Cutolo M, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Grassi W, Lapadula G, Cerinic MM, Montecucco C, Trotta F, Triolo G, Valentini G, Valesini G, Ferraccioli GF; GISEA group.

J Rheumatol. 2007 Aug;34(8):1670-3. Epub 2007 Jul 1. Erratum in: J Rheumatol. 2007 Sep;34(9):1947.

PMID:
17611987
[PubMed - indexed for MEDLINE]
17.

CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritis.

Krintel SB, Essioux L, Wool A, Johansen JS, Schreiber E, Zekharya T, Akiva P, Ostergaard M, Hetland ML.

PLoS One. 2012;7(6):e38539. doi: 10.1371/journal.pone.0038539. Epub 2012 Jun 7.

PMID:
22685579
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.

Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, Hansen IT, Kollerup G, Linde L, Lindegaard HM, Poulsen UE, Schlemmer A, Jensen DV, Jensen S, Hostenkamp G, Østergaard M; All Departments of Rheumatology in Denmark.

Arthritis Rheum. 2010 Jan;62(1):22-32. doi: 10.1002/art.27227.

PMID:
20039405
[PubMed - indexed for MEDLINE]
Free Article
19.

Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.

Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Thorne JC, Paul Haraoui B, Psaradellis E, Sampalis J, Bonner A.

Semin Arthritis Rheum. 2011 Aug;41(1):81-9. doi: 10.1016/j.semarthrit.2010.09.004. Epub 2010 Dec 17.

PMID:
21168187
[PubMed - indexed for MEDLINE]
20.

The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug.

Söderlin MK, Petersson IF, Geborek P.

Scand J Rheumatol. 2012 Feb;41(1):1-9. doi: 10.3109/03009742.2011.599073. Epub 2011 Nov 28.

PMID:
22118371
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk